Pharmacy practice
Pérez Velasco R.
PMID: 25126143
Pharm Pract (Granada). 2010 Oct;8(4):213-9. doi: 10.4321/s1886-36552010000400002.
UNLABELLED: Granulocyte colony-stimulating factors (G-CSF) are high-cost agents recommended as prophylaxis of febrile neutropenia or as adjunctive treatment of severe neutropenic sepsis. Their use in high-risk situations such as acute myeloid leukaemia, acute lymphocytic leukaemia, myelodysplastic syndrome and stem...
Cite
Pérez Velasco R. Granulocyte colony-stimulating factor use in a large British hospital: comparison with published experience. Pharm Pract (Granada). 2010;8(4):213-9doi: 10.4321/s1886-36552010000400002.
Pérez Velasco, R. (2010). Granulocyte colony-stimulating factor use in a large British hospital: comparison with published experience. Pharmacy practice, 8(4), 213-9. https://doi.org/10.4321/s1886-36552010000400002
Pérez Velasco, Román. "Granulocyte colony-stimulating factor use in a large British hospital: comparison with published experience." Pharmacy practice vol. 8,4 (2010): 213-9. doi: https://doi.org/10.4321/s1886-36552010000400002
Pérez Velasco R. Granulocyte colony-stimulating factor use in a large British hospital: comparison with published experience. Pharm Pract (Granada). 2010 Oct;8(4):213-9. doi: 10.4321/s1886-36552010000400002. PMID: 25126143; PMCID: PMC4127058.
Copy
Download .nbib